Astal Laboratories share news, announcements and annual reports
BSE: 512600Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 27 Oct 2026. Previous close ₹65.96.
27 Oct: open ₹66.95, high ₹67.95, low ₹66.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹293 Cr2,455th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 30.08
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 0.88
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 4.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.15
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,382
Astal Laboratories has 547 announcements on record, routine notices left out; 5 in the 30 days to 28 Oct 2026, the latest on 30 Sep 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Astal Laboratories quarterly results
The board met on 14 Aug 2026 to consider quarterly results
Notice filed 10 Aug 2026
Astal Laboratories annual reports, presentations and earnings calls
The company's own documents, latest first.Astal Laboratories financials, year by year
Annual reports26
- Annual report, year to Mar 20267 Sep 2026
- Annual report, year to Mar 202518 Aug 2025
- Annual report, year to Mar 202412 Jul 2024
- Annual report, year to Mar 202316 Sep 2023
- Annual report, year to Mar 20228 Sep 2022
21 earlier reports
- Annual report, year to Mar 20211 Sep 2021
- Annual report, year to Mar 202010 Sep 2020
- Annual report, year to Mar 201914 Sep 2019
- Annual report, year to Mar 20181 Oct 2018
- Annual report, year to Mar 201714 Nov 2017
- Annual report, year to Mar 201616 Sep 2016
- Annual report, year to Mar 201521 Sep 2015
- Annual report, year to Mar 201411 Sep 2014
- Annual report, year to Mar 201326 Jul 2013
- Annual report, year to Mar 2012Filing day not known
- Annual report, year to Mar 20114 Feb 2012
- Annual report, year to Mar 2006Filing day not known
- Annual report, year to Mar 2005Filing day not known
- Annual report, year to Mar 2004Filing day not known
- Annual report, year to Mar 2003Filing day not known
- Annual report, year to Mar 2002Filing day not known
- Annual report, year to Mar 2001Filing day not known
- Annual report, year to Mar 2000Filing day not known
- Annual report, year to Mar 1999Filing day not known
- Annual report, year to Mar 1998Filing day not known
- Annual report, year to Mar 1997Filing day not known
Astal Laboratories share news and announcements
Newest first. Page 1 of 11.
Sep 2026
30 Sep · Results
30 Sep · Meeting
30 Sep · Management
30 Sep · Management
29 Sep · Meeting
11 Sep · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
7 Sep · Meeting
7 Sep · Meeting
5 Sep · Meeting
5 Sep · Management
4 Sep · Board meeting
Aug 2026
31 Aug · Board meeting
Meeting on 4 Sep 2026: annual general meeting14 Aug · Business
14 Aug · Results
10 Aug · Board meeting
Meeting on 14 Aug 2026: quarterly results
Jun 2026
29 Jun · Board meeting
1 Jun · Announcement Under Regulation 30 (LODR) 2015- Authorization Of Kmps Under Regulation 30(5)
May 2026
31 May · Management
30 May · Results
30 May · Business
30 May · Results
26 May · Announcement Under Regulation 30 (LODR)- Lapse Of Convertible Warrants.
26 May · Announcement under Regulation 30 (LODR)-Allotment
25 May · Board meeting
Meeting on 30 May 2026: quarterly results and audited results25 May · Board meeting
15 May · Business
12 May · Announcement under Regulation 30 (LODR)-Allotment
12 May · Board meeting
11 May · Legal
Exchange has sought clarification from Astal Laboratories Ltd on May 11, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Apr 2026
30 Apr · Intimation Under Regulation 30 (LODR), 2015- Website
Mar 2026
19 Mar · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Feb 2026
14 Feb · Business
14 Feb · Results
10 Feb · Board meeting
Meeting on 14 Feb 2026: quarterly results
Jan 2026
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 14 May 2026Board or managers changeddown 1.23%−2.3 pts vs Nifty 500market median 0.0% · five sessions −3.3% (−4.2 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 7 Aug 2024Board or managers changedup 2.00%+0.2 pts vs Nifty 500market median 0.0% · five sessions +2.8% (+1.7 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 17 Jul 2023Board or managers changeddown 4.99%−5.6 pts vs Nifty 500market median 0.0% · five sessions −5.5% (−6.3 pts vs Nifty 500) · volume 1.0× usual · The announcement
- 26 Jun 2023Board or managers changedup 4.97%+5.4 pts vs Nifty 500market median 0.0% · five sessions −14.5% (−19.0 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 24 Oct 2022Board or managers changed0.00%−2.0 pts vs Nifty 500market median 0.0% · volume 0.6× usual · The announcement
- 17 Oct 2022Board or managers changed–market median 0.0% · volume 0.0× usual · The announcement
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Dealing with a related party in the period | Quarter to Mar 2025 | Standalone | 0.45 | 0.43 | −4.5% | 12 Jun 2025 | 12 Jun 2025 |